From: Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation
Group
Case
AFP(ng/mL)
AFP-L3(%)
CTCs
OS>3 years
40
162.28(67.93~427.05)
14.95(13.87~15.84)
2.25(1.95~2.53)
OS<3 years
52
270.33(154.62~731.85)a
18.81(16.32~19.26)a
2.72(2.33~2.93)a